EXECUTIVE EMPLOYMENT AGREEMENT AURINIA PHARMACEUTICALS INC.Executive Employment Agreement • February 24th, 2021 • Aurinia Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
This Agreement confirms the terms and conditions of your employment by the Corporation and will constitute your employment agreement. Those terms and conditions are set out below:
SOFTGEL COMMERCIAL SUPPLY AGREEMENTSoftgel Commercial Supply Agreement • February 24th, 2021 • Aurinia Pharmaceuticals Inc. • Pharmaceutical preparations • New Jersey
This Softgel Commercial Supply Agreement ("Agreement") is made as of this 28th day of August 2020 ("Effective Date"), by and between Aurinia Pharmaceuticals Inc., an Alberta Canada corporation, with a place of business at 1203-4464 Markham St., Victoria, British Columbia V8Z 7X8, Canada ("Client"), and Catalent Pharma Solutions, LLC, a Delaware limited liability company, having a place of business at 14 Schoolhouse Road, Somerset, New Jersey 08873 ("Catalent").
ContractSettlement Agreement • February 24th, 2021 • Aurinia Pharmaceuticals Inc. • Pharmaceutical preparations • Alberta
This tripartite Settlement agreement is made on April 3 2013 by and among Isotechnika Pharma Inc., incorporated pursuant to the laws of Alberta, Canada and having their principal office at 5120-751h St. Edmonton Alberta, Canada T6ER-6W2, ("ISOTECHNIKA") ILJIN Life Science Co. Ltd., a corporation, with its principal office at ILJIN Building, 50-1 Dowha-Dong, Mapo-Gu, Seoul, Korea ("ILJIN"), and Aurinia Pharmaceuticals Inc., incorporated pursuant to the laws of British Columbia, Canada having their principal office at #1203-4464 Markham St. Victoria, British Columbia Canada V8Z 7X8. ("AURINIA"). Collectively ISOTECHNIKA, ILJIN and AURINIA are referred to as the "Parties"
INDEMNITY AGREEMENTIndemnity Agreement • February 24th, 2021 • Aurinia Pharmaceuticals Inc. • Pharmaceutical preparations • Alberta
IN WITNESS WHEREOF in consideration of the premises and the sum of ONE DOLLAR ($1.00) now paid by the Executive to Aurinia (the receipt and sufficiency of which is acknowledged by Aurinia) and in consideration of the mutual promises and covenants herein contained, the parties agree as follows:
EMPLOYMENT AGREEMENT AURINIA PHARMA U.S., INC.Employment Agreement • February 24th, 2021 • Aurinia Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
This Employment Agreement ("Agreement'') sets forth the terms and conditions of your employment with Aurinia Pharma U.S., Inc. (the "Corporation "), a Delaware corporation and wholly owned subsidiary of Aurinia Pharmaceuticals Inc., a corporation under the laws of the Province of Alberta ("Parent'), and will constitute your employment agreement. Those terms and conditions are set out below:
OFFICE LEASE between BOF II MD 77 UPPER ROCK LLC, (Landlord) and AURINIA PHARMA U.S., INC. (Tenant) 77 UPPER ROCK CIRCLE Rockville, MarylandOffice Lease • February 24th, 2021 • Aurinia Pharmaceuticals Inc. • Pharmaceutical preparations • Maryland
purchase and install Tenant’s telecommunication cabling and equipment, (iii) so-called “soft costs” (including permitting fees), and (iv) upon written notice to Landlord, the next coming Base Rent due under the Lease. Any portion of the Tenant Improvement Allowance not used by Tenant in accordance with the terms of this Work Letter within [redacted] after the Effective Date of the Lease shall be deemed forfeited by Tenant. All of the Tenant Work paid for by Landlord shall be the property of Landlord and shall be depreciated by Landlord.
Manufacturing Services Agreement (the “Agreement”)Services Agreement • February 24th, 2021 • Aurinia Pharmaceuticals Inc. • Pharmaceutical preparations • New York
VANCOUVER ISLAND TECHNOLOGY PARKAurinia Pharmaceuticals Inc. • February 24th, 2021 • Pharmaceutical preparations • British Columbia
THIS LEASE, dated for reference this 30th day of October , 2020 is made by the Landlord and Tenant named below who, in consideration of the covenants in this Lease, agree as follows:
Re: Revised Transition and Separation Agreement Dear Erik:Aurinia Pharmaceuticals Inc. • February 24th, 2021 • Pharmaceutical preparations • Illinois
This letter sets forth the terms of the transition and separation agreement (the “Agreement') that Aurinia Pharma U.S., Inc. (the "Company"), a Delaware corporation and a wholly owned subsidiary of Aurinia Pharmaceuticals Inc., a corporation under the laws of the Province of Alberta ("Parent") is offering to you to aid in your employment transition.
Re: Executive Employment Agreement with Aurinia Pharmaceuticals Inc.Aurinia Pharmaceuticals Inc. • February 24th, 2021 • Pharmaceutical preparations • British Columbia
We are pleased to offer you employment with Aurinia Pharmaceuticals Inc. (the "Company") as the Company's Executive Vice President, General Counsel, Corporate Secretary, and Chief Compliance Officer. This offer is subject to your acceptance of the terms and conditions set forth in this Executive Employment Agreement (this "Employment Agreement") and the attached Employee Confidentiality, Intellectual Property, and Restrictive Covenant Agreement (the "Confidentiality Agreement"). This offer will expire on October 15, 2020, unless extended in writing by the Company. Please indicate your acceptance of this offer by signing and returning a copy of this Employment Agreement and the attached Confidentiality Agreement to me by email in PDF format to [redacted] no later than this date. The terms and conditions of your employment with the Company are set out below.
EXECUTIVE EMPLOYMENT AGREEMENT AURINIA PHARMA U.S., INC.Executive Employment Agreement • February 24th, 2021 • Aurinia Pharmaceuticals Inc. • Pharmaceutical preparations • Maryland
This Agreement confirms the terms and conditions of your employment by Aurinia Pharma U.S., Inc. (the “Corporation”), a Delaware corporation and a wholly-owned subsidiary of Aurinia Pharmaceuticals Inc., a corporation under the laws of the Province of Alberta (“Parent”), and will constitute your employment agreement. The terms and conditions of your employment are set out below:
OFFICE LEASEOffice Lease • February 24th, 2021 • Aurinia Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
Page Part 1 DEFINITIONS/SCHEDULES 5 1.1 Defined Terms 5 1.2 Schedules 13 Part 2 INTENT 13 2.1 Net Lease 13 Part 3 PREMISES, TERM 13 3.1 Demise 13 Part 4 RENT AND ADDITIONAL RENT 13 4.1 Covenant to Pay Rent 13 4.2 Basic Rent 13 4.3 Certification of Rentable Area. 14 4.4 Additional Rent 14 4.5 Payment of Additional Rent 16 4.6 Method of Payment 16 4.7 Dispute as to Costs 16 4.8 Security Deposit 17 Part 5 ALLOCATIONS OF HVAC COSTS AND ELECTRICAL COSTS 17 5.1 Allocation of HVAC Costs 17 5.2 Allocation of Electrical Costs 17 Part 6 USE OF PREMISES AND TENANT COVENANTS 17 6.1 Permitted Business 17 6.2 Conduct of Business 17 6.3 Display of Name of Tenant 17 6.4 No Canvassing 17 6.5 Operations by Tenant 17 6.6 Relocation of the Premises 18
EMPLOYMENT AGREEMENT AURINIA PHARMA U.S., INC.Employment Agreement • February 24th, 2021 • Aurinia Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
This Employment Agreement (''Agreement'') sets forth the terms and conditions of your employment with Aurinia Pharma U.S., Inc. (the "Corporation"), a Delaware corporation and wholly owned subsidiary of Aurinia Pharmaceuticals Inc., a corporation under the laws of the Province of Alberta ("Parent'), and will constitute your employment agreement. Those terms and conditions are set out below:
April 8, 2020 Joseph Miller [redacted] Re: Terms of Employment with Aurinia Pharma U.S., Inc. Dear Joseph:Aurinia Pharmaceuticals Inc. • February 24th, 2021 • Pharmaceutical preparations • Maryland
Aurinia Pharma U.S., Inc. (the "Company"), a Delaware Corporation and wholly owned subsidiary of Aurinia Pharmaceuticals Inc., a corporation under the laws of the Province of Alberta ("Parent"), is pleased to offer you employment as the Company's Chief Financial Officer ("CFO"), on the terms and conditions set forth in this letter agreement (the "Agreement").
